Revolutionizing drug screening with Tempus AI’s advanced imaging capabilities

Learn how Tempus AI's noninvasive imaging techniques allow for the continuous study of the same organoids across various assays, preserving their viability for longitudinal analysis and multiplexed testing.

Oct 11, 2024
Life Sciences
Case Study